Hypercalcemia is a common condition in the internal medicine practice. Sometimes its cause is not readily apparent, so extensive investigation is appropriate. Here we report an unexpected cause for hypercalcemia in an elderly woman. The case of an 82-years old woman with PTH-independent hypercalcemia, lymphocytosis, normal serum 1,25 (OH)vitamin D levels, and low serum PTHrp levels, is described. Medical history and complementary investigation were unremarkable, except for increased metabolic activity in the glutei regions, as measured by whole body 18F-FDG PET-CT. Reviewing her medical history, her sister recalled that she had been submitted to intramuscular methylmethacrylate injections, for cosmetic purposes, five years before presentation, which was confirmed by muscle biopsy. Low calcium intake, parenteral bisphosphonates, calcitonin, and glucocorticoids were used to control serum calcium levels. Methylmethacrylate injections, used cosmetically, are a new cause for hypercalcemia, even after many years. Hypercalcemia was probably due to calcitriol overproduction in foreign body granulomas. Persistent reactive lymphocytosis could be a clue for this inflammatory cause of hypercalcemia. Arch Endocrinol Metab. 2015;59(3):277-80
INTRODUCTION
H ypercalcemia is a relatively common problem in clinical practice. Sometimes the cause is not readily apparent, so extensive investigation is appropriate. Here we report an unexpected cause for hypercalcemia in an elderly woman.
CASE REPORT
An 82-years old woman presented with recurrent episodes of confusion, delirium, and somnolence or stupor, for the past 6 months. Her previous medical history was unremarkable, except for previous 20 pack years smoking and systemic arterial hypertension. She has been using daily hydrochlorothiazide 25 mg, amiloride 2.5 mg, vitamin D3 2000 IU, and calcium carbonate 2 g. There were no previous surgeries or hospital admissions. The physical exam was unremarkable, except for low BMI (17 Kg/m 2 ). Initial evaluation, as shown in table 1, disclosed severe PTH-independent hypercalcemia, lymphocytosis, and no vitamin D intoxication. All her medications were stopped, and, as serum phosphate level was in the low reference range and tubular reabsorption of phosphate was low, a probable malignant cause was searched for. Computed tomography (CT) of neck, thorax, and abdomen, revealed a small swelling of the pyriform sinus, and simple renal and ovarian cysts, up to 1.2 cm; fiberoptic indirect and direct laryngoscopy identified no lesion, and biopsies of the pyriform sinus region had no tumor; bone scintigraphy, bone marrow aspiration, peripheral blood cells immunophenotyping, serum and urine protein electrophoresis, and upper gastrointestinal endoscopic study were normal. Transvaginal pelvic ultrasound confirmed the presence of a simple ovarian cyst. A whole body 18F-FDG PET-CT showed extensive and symmetric increased metabolic activity in the glutei regions, as shown in figure 1A . At inspection, bilateral glutei regions were normal, but irregular 2-3 cm hard nodules were identified by palpation. The abdominal CT was reviewed with identification of extensive areas of increased density and loss of definition of both gluteus maximus, as shown in figure 1B . Reviewing the medical history, her sister recalled that she has been submitted to intramuscular methylmethacrylate injections in the glutei regions for cosmetic reasons, five years before presentation. A gluteus muscle biopsy showed chronic inflammation with fibrosis, histiocytes, lymphocytes, and giant cells around foreign body, compatible with methylmethacrylate ( Figure 2) . A surgical consultation was made, but resection of the lesions was not indicated due to its extension. At this point serum PTHrp and calcitriol levels were available: PTHrp: below 0.8 pmol/L (reference range < 1.3 pmol/L; chemiluminescence); calcitriol: 34 pg/ mL (reference range 18 -78 pg/mL; radioimmunoassay). Dietary calcium was reduced to 350 mg/day, and 40 mg of oral prednisone was prescribed for 10 days and increased to 80 mg/day thereafter. Two weeks later, serum calcium levels were within the reference range, as well as blood lymphocytes, so prednisone was tapered to 20 mg/day. During the investigation and follow-up, saline infusion, calcitonin, and intravenous bisphosphonates were also used. These data are depicted in figure 3 . Twelve months later, the patient had normal serum calcium levels. Written informed consent was obtained to report this case. 
DISCUSSION
In this report, a patient with PTH-independent hypercalcemia, and non-monoclonal persistent lymphocytosis is described. The investigation was negative for cancer and identified a PTH-independent, calcitriol-mediated hypercalcemia secondary to foreign body granulomas induced by intramuscular methylmethacrylate, with a good response to oral prednisone. The milk-alkali syndrome was excluded due to the normal serum bicarbonate levels at presentation. The most widely known granulomatous diseases causing hypercalcemia are tuberculosis, sarcoidosis, and systemic fungal infections. Hypercalcemia in these situations is mostly attributed to increase in serum calcitriol levels, due to higher 1alfa-hydroxylase activity in activated macrophages (1, 2) , although, in some patients, hypercalcemia has been associated with PTHrp (3, 4) . In several patients with granulomatous diseases and hypercalcemia, serum calcitriol levels have been in the normal range, which are inappropriately high, considering the low serum PTH levels (2) . In these patients, serum vitamin D levels probably did not reflect tissue-level vitamin D (5).
Less commonly, other causes of granulomatous reactions have been associated with hypercalcemia, also with elevated calcitriol levels (1), as foreign body reaction to silicone (6), paraffin (7), and talc (8) . In our patient, hypercalcemia was very probably mediated by calcitriol, as serum PTH and PTHrp levels were not detectable (5) .
Recently four cases of hypercalcemia associated with methylmethacrylate injection have been described in Buenos Aires, Argentina (9). All patients had severe hypercalcemia, low or suppressed PTH levels, and high or inappropriately normal serum calcitriol levels (9) .
Some features of the present case are not completely clear. Although at presentation the patient was taking 2000 IU of vitamin D3 daily, serum 25-OH-vitamin D levels were low. Several factors might have contributed to it: irregular intake of the prescribed vitamin D, decreased vitamin D absorption, and increased conversion of 25-OH-vitamin D to its metabolites in the granulomas. Also, serum phosphate levels and tubular reabsorption of phosphate were lower than expected. Bisphosphonate use and malnutrition could explain the serum phosphate levels, but not the increased phosphate excretion.
